Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jerry Shapiro Insider Profile
4 Followers
Jerry Shapiro, Ten Percent Owner at RepliCel Life Sciences, holds 4.24M shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Jerry Shapiro Bought $1,523,162 shares of RepliCel Life Sciences on Mar 02, 2012 for an estimated value of ―.
Jerry Shapiro has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Jerry Shapiro holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 02, 2012 - Mar 02, 2013
Return:-80.00%
The most profitable trade made by Jerry Shapiro
Jerry Shapiro's Trading History
List of latest transactions for each holding click on a transaction to see Jerry Shapiro's performance on stock
You May Also Like
Jerry Shapiro insider profile FAQ
What is the percentage of profitable transactions made by Jerry Shapiro?
The percentage of profitable transactions made by Jerry Shapiro is ―.
What is the average return per transaction made by Jerry Shapiro?
The average return per transaction made by Jerry Shapiro is ―.
What stocks does Jerry Shapiro hold?
Jerry Shapiro holds: REPCF stocks.
What was Jerry Shapiro’s latest transaction?
Jerry Shapiro latest transaction was an Informative Buy of ―.
What was Jerry Shapiro's most profitable transaction?
Jerry Shapiro’s most profitable transaction was an Informative Buy of REPCF stock on March 2, 2012. The return on the trade was -80.00%.
What is Jerry Shapiro's role in RepliCel Life Sciences?
Jerry Shapiro's role in RepliCel Life Sciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.